New molecules and biopharmaceuticals enhance patient's immune response against tumors

[News]

Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that enhance a patient's immune response against tumors.

More... (http://www.news-medical.net/news/20140722/New-molecules-and-biopharmaceuticals-enhance-patients-immune-response-against-tumors.aspx)